Quick Answer
CUMBERLAND PHARMACEUTICALS INC reported Total Revenue of $44.52 million for fiscal year 2025.
CUMBERLAND PHARMACEUTICALS INC Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $44.52M | +17.6% |
| 2024 | $37.87M | -4.3% |
| 2023 | $39.55M | -5.9% |
| 2022 | $42.01M | +16.7% |
| 2021 | $35.99M | -3.9% |
| 2020 | $37.44M | +8.9% |
| 2019 | $34.39M | +17.2% |
| 2018 | $29.34M | -28.7% |
| 2017 | $41.15M | +24.6% |
| 2016 | $33.03M | -1.5% |
| 2015 | $33.52M | -9.2% |
| 2014 | $36.90M | +15.2% |
| 2013 | $32.03M | -34.4% |
| 2012 | $48.85M | -4.5% |
| 2011 | $51.14M | +11.5% |
| 2010 | $45.88M | +5.4% |
| 2009 | $43.54M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $8.29M | -8.7% | -23.5% |
| June 30, 2025 | $10.84M | +10.0% | -7.5% |
| March 31, 2025 | $11.71M | +37.8% | +28.9% |
| September 30, 2024 | $9.09M | -9.9% | -7.7% |
| June 30, 2024 | $9.85M | -9.6% | +15.9% |
| March 31, 2024 | $8.50M | -7.9% | -15.7% |
| September 30, 2023 | $10.09M | -11.6% | -7.4% |
| June 30, 2023 | $10.89M | +5.7% | +18.0% |
- CUMBERLAND PHARMACEUTICALS INC showed an increase of +17.6% in Total Revenue compared to the prior fiscal year.
- Over the 2009–2025 period, CUMBERLAND PHARMACEUTICALS INC’s total revenue has grown by 2.3% (from $43.54 million to $44.52 million).
- The most recent figure is from CUMBERLAND PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: